Cann Compounding Group
Cann Compounding Group is an Australian compounding pharmacy operating purpose-built facilities in Adelaide and Brisbane that produce personalised prescription medications — including veterinary and women's health formulations — for patients and prescribing healthcare professionals, supplemented by doctor consultations and a retail supplement and medical device storefront.
- Company typePrivate
- Founded2022
- HeadquartersGlynde, Adelaide, Australia
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Cann Compounding Group does
Cann Compounding Group operates as an Australian compounding pharmacy group that produces personalised medications for individual patients based on valid prescriptions. The company runs two purpose-built compounding facilities — its Adelaide (Glynde) flagship opened in October 2022 as the first compounding-only pharmacy in Australia, and a Brisbane (Wakerley) facility added in Q1 2024 featuring three specialised labs, advanced quality testing, and substantial vault space. Operations span non-sterile and sterile compounding under Australian (APF, Pharmacy Board of Australia, TGA) and international (USP, EP, BP) standards, with the Vapormed Volcano Medic 2 holding ARTG registration (ARTG 319028).
The product portfolio centres on custom compounded medications in multiple dosage forms — gummies, capsules, creams, ointments, oils, pessaries, and suppositories — and is organised around specialty divisions including Cann Compounding Vet for veterinary formulations and a Women's Health Program targeting conditions such as PMDD, endometriosis, and chronic pelvic pain. Adjacent offerings include Dr Anita integrative medical consultations, an e-commerce storefront distributing premium third-party supplements (Infinity Wellness, Perdays, EZZ, BN, Life Cykel) and medical vaporiser devices, plus niche services such as terpene-based formulations, nicotine cessation support, and device cleaning.
The commercial model is a hybrid B2B2C and direct-to-consumer operation: healthcare professionals (GPs, specialists, veterinarians) submit prescriptions via dedicated SMS/email channels to either facility, with most standard formulas turned around within 48 hours, while patients also visit in-pharmacy, book Dr Anita consultations, or purchase retail health products online. Cann Compounding sits within the Crisci Group, a privately held diversified parent led by CEO David Crisci, with Mei Hui Mah as COO, Dr Kylie O'Brien as CSO, and Matthew Soliman as Head of Product Development.
Cann Compounding Group firmographics
Firmographics- Name
- Cann Compounding Group
- Legal name
- Cann Compounding
- Website
- https://canncompounding.com.au
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cann Compounding Group is an Australian compounding pharmacy operating purpose-built facilities in Adelaide and Brisbane that produce personalised prescription medications — including veterinary and women's health formulations — for patients and prescribing healthcare professionals, supplemented by doctor consultations and a retail supplement and medical device storefront.
- Ownership category
- akta.pro rank
Cann Compounding Group industry classification
Industry- Product category
- Compounding Pharmacy Services
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)
- akta.pro secondary industries
- Medication Adherence, Reminders & Patient Support (HLACAKAF), Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)
Keywords
Where Cann Compounding Group is headquartered
LocationHeadquarters
- HQ city
- Glynde, Adelaide
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Cann Compounding Group business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Compounded Medications: Personalised prescribed medications prepared for individual patients based on valid prescriptions. Revenue generated from custom formulations for pain management, sleep, anxiety, women's health, and veterinary compounds. Turnaround typically within 48 hours of receiving an order.
- Retail Health Products: Sale of premium supplements, accessories, and wellness products through the online shop. Products include probiotics, vitamins, mushroom extracts, protein powders, and medical devices such as vaporisers. Prices range from approximately $20 to $890 per item.
- Medical Consultations: Doctor consultation services providing personalised integrative care. First consultations are $160 with $84.90 Medicare rebate (Gap: $75.10). Review consultations are $99 with $43.90 Medicare rebate (Gap: $55.10).
- Nicotine Cessation Products: Nicotine vaping products and cessation support formulations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Health Supplements |
| Unit Pricing | Pay-as-you-go | Doctor Consultations - First Visit |
| Unit Pricing | Pay-as-you-go | Doctor Consultations - Review |
| Unit Pricing | Pay-as-you-go | Medical Devices |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels3 records
Cann Compounding Group product offering
Product offeringCore offering
Cann Compounding Group prepares personalised compounded medications in multiple dosage forms (gummies, capsules, creams, ointments, oils, pessaries, suppositories) at its purpose-built Adelaide and Brisbane facilities, fulfilling prescriptions submitted by patients and healthcare professionals via SMS, email or in-pharmacy visits. It also retails premium supplements, accessories and TGA-registered medical vaporisers, and offers integrative doctor consultations through Dr Anita and a dedicated women's health and veterinary compounding program.
Product overview
Cann Compounding Group operates as a compounding pharmacy with a platform of specialised pharmaceutical services. The core offering is custom compounded medications in various dosage forms (gummies, capsules, creams, ointments, oils, pessaries, suppositories), supported by two state-of-the-art facilities in Adelaide and Brisbane. The company operates three specialty divisions: Cann Compounding Vet for veterinary compounding, the Women's Health Program for hormonal and reproductive health conditions, and Dr Anita Consultations for integrative medical care. The product portfolio includes retail supplements (Infinity Wellness, Perdays, EZZ, BN, Life Cykel, Plant Based Protein), medical devices (Vapormed Mighty+ Medic, Volcano Medic 2), and accessories (satinca range), alongside specialised services such as nicotine cessation support, terpene-based formulations, and prescription delivery.
Differentiator
Problem solved
Functional benefit
Products and services
- Custom Compounded Medications
Quantifiable outcome
- Most standard compounded formulas are ready to be sent out within 48 hours of receiving an order
- +1 more outcomes
Companies that use Cann Compounding Group
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Cann Compounding Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Cann Compounding Group partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Dr Anita (Dr. Anita Integrative Medicine)coreDr Anita provides personalised, face-to-face integrative care and medical consultations at Cann Compounding SA. She specialises in chronic pain, mental health, and women's health with a holistic lens. Her focus on PMDD, endometriosis, and chronic pelvic pain aligns with Cann Compounding's personalised medicine approach. Consultations available by booking.
Scale indicators4 records
Recent moves8 records
Expansion highlights5 records
Cann Compounding Group competitors and assessment
Company assessmentEmerging players
- Strive Compounding Pharmacy: Australian bespoke compounding pharmacy focused on personalised medications, particularly bioidentical hormones and dermatological preparations. Comparable emerging competitor in the personalised medicine niche with overlapping dosage form capabilities.
Direct peers
- Slade Pharmacy: Australia's largest compounding pharmacy operator serving hospital, oncology, and community patients with sterile and non-sterile preparations. Comparable scale and breadth of compounding capability from a competing Australian operator.
- National Custom Compounding (NCC): Australian compounding-only pharmacy producing personalised medications across dosage forms for patients and prescribers. Cann Compounding and NCC are direct counterparts in the dedicated compounding pharmacy category in Australia.
- Pharmacy 777 Compounding: National pharmacy chain offering personalised compounding services alongside retail pharmacy. Comparable community-focused compounding service offering competing for the same prescriber and patient base in Australia.
Broad incumbents
- TerryWhite Chemmart Compounding: Major Australian pharmacy network with selected stores offering compounding services. Comparable end-market but operates compounding as one of many services within a broader retail pharmacy portfolio.
- Chemist Warehouse Compounding: Largest Australian pharmacy retailer offering some compounding and personalised medication services. Comparable on patient/customermarket but mass-market positioning contrasts with Cann Compounding's specialist focus.
Others
- Medisca: Global supplier of compounding chemicals, bases, and equipment, plus training for compounding pharmacists. Adjacent comparator as the supplier infrastructure behind independent compounding pharmacies like Cann Compounding.
- PCCA (Professional Compounding Centers of America): Bulk supplier of APIs, bases, equipment, and training to compounding pharmacies globally. Comparable through supporting compounding pharmacy operations, though PCCA is an upstream supplier rather than a service competitor.
- ReLeaf Dispensaries: Sister brand within the Crisci Group providing medicinal cannabis dispensing. Comparable as a sibling brand under common ownership serving complementary patient populations in the Australian personalised medicine ecosystem.
Regional players
- Blooms The Chemist Compounding: Australian pharmacy group with compounding capabilities at selected locations across multiple states. Comparable community-oriented compounding offering with similar regulatory and operational requirements to Cann Compounding.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Cann Compounding Group social profiles
Digital presenceCann Compounding Group compliance and trust
Trust signalCompliance6 records
Cann Compounding Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cann Compounding Group leadership team
Management profileNumber of profiles
Profiles1 record
Cann Compounding Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cann Compounding Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cann Compounding Group
What does Cann Compounding Group do?
Cann Compounding Group prepares personalised compounded medications in multiple dosage forms (gummies, capsules, creams, ointments, oils, pessaries, suppositories) at its purpose-built Adelaide and Brisbane facilities, fulfilling prescriptions submitted by patients and healthcare professionals via SMS, email or in-pharmacy visits. It also retails premium supplements, accessories and TGA-registered medical vaporisers, and offers integrative doctor consultations through Dr Anita and a dedicated women's health and veterinary compounding program.
Is Cann Compounding Group a public or private company?
Cann Compounding Group is a private company. It is classified as family owned and is currently operating.
When was Cann Compounding Group founded?
Cann Compounding Group was founded in 2022. It employs 1 to 10 people.
Where is Cann Compounding Group based?
Cann Compounding Group is headquartered in Glynde, Adelaide, Australia, in the Oceania region.
How does Cann Compounding Group make money?
Four revenue lines are on record. Compounded Medications are the primary driver. The others are retail Health Products, medical Consultations and nicotine Cessation Products.
Who are Cann Compounding Group's main competitors?
Strive Compounding Pharmacy is listed as an emerging player. Direct peers are Slade Pharmacy, National Custom Compounding (NCC) and Pharmacy 777 Compounding. Broad incumbents are TerryWhite Chemmart Compounding and Chemist Warehouse Compounding. Others are Medisca, PCCA (Professional Compounding Centers of America) and ReLeaf Dispensaries. Blooms The Chemist Compounding is listed as a regional player.
Does Cann Compounding Group have an API?
No public API is recorded for Cann Compounding Group.
What industry is Cann Compounding Group in?
Cann Compounding Group's product category is Compounding Pharmacy Services. Its primary akta.pro industry code is HLAFALAE, Compounding Pharmacies (Sterile/Non-Sterile), with a secondary code of HLACAKAF, Medication Adherence, Reminders & Patient Support. Its NAICS code is 325412 and its SIC code is 2834.